Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nucana PLC

0.7605
-0.0385-4.82%
Post-market: 0.80000.0395+5.19%19:01 EDT
Volume:37.22K
Turnover:29.17K
Market Cap:2.99M
PE:-0.05
High:0.8000
Open:0.7990
Low:0.7513
Close:0.7990
Loading ...

NuCana Announces Grant of Composition-of-Matter Patent for Nuc-7738 in the United States

THOMSON REUTERS
·
26 Sep 2024

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

GlobeNewswire
·
26 Sep 2024

European Equities Traded in the US as American Depositary Receipts Trend Lower Wednesday

MT Newswires Live
·
25 Sep 2024

European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading

MT Newswires Live
·
18 Sep 2024

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading

MT Newswires Live
·
17 Sep 2024

NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study

Zacks
·
17 Sep 2024

Truist Financial Keeps Their Buy Rating on Nucana (NCNA)

TIPRANKS
·
17 Sep 2024

Top Midday Gainers

MT Newswires Live
·
17 Sep 2024

European Equities Close Mostly Lower in Monday Trading; Deutsche Bank Aims to Block UniCredit From Buying Commerzbank Stake

MT Newswires Live
·
17 Sep 2024

Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September

Benzinga
·
16 Sep 2024

NuCana Resistant Melanoma Treatment Data Shows Providing Some Relief After Disappointing Colorectal Cancer Data, Stock Surges

Benzinga
·
16 Sep 2024

Fed Meeting Looms, Driving Mixed Premarket Activity for US Equity Futures

MT Newswires Live
·
16 Sep 2024

Oppenheimer Sticks to Their Buy Rating for Nucana (NCNA)

TIPRANKS
·
16 Sep 2024

Top Premarket Gainers

MT Newswires Live
·
16 Sep 2024

NuCana Reports Breakthrough in Resistant Melanoma Treatment

TIPRANKS
·
16 Sep 2024

NuCana ADRs Nearly Double on Positive Data From Metastatic Melanoma Treatment

Dow Jones
·
16 Sep 2024